Literature DB >> 23892913

Lyonization in ophthalmology.

Wadakarn Wuthisiri1, Michelle D Lingao, Jenina E Capasso, Alex V Levin.   

Abstract

PURPOSE OF REVIEW: To describe the entity of Lyonization in ocular eye diseases, along with its clinical and counseling implications. RECENT
FINDINGS: Several X-linked ocular diseases such as choroideremia, X-linked retinitis pigmentosa, and X-linked ocular albinism may have signs of Lyonization on ocular examination and diagnostic testing. These findings may aid in the proper diagnosis of ocular disease in both female carriers and their affected male relatives.
SUMMARY: Manifestations of Lyonization in the eye may help in the diagnosis of X-linked ocular diseases which may lead to accurate diagnosis, appropriate molecular genetic testing and genetic counseling.

Entities:  

Mesh:

Year:  2013        PMID: 23892913     DOI: 10.1097/ICU.0b013e3283641f91

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  4 in total

1.  CHOROIDEREMIA ASSOCIATED WITH A NOVEL SYNONYMOUS MUTATION IN GENE ENCODING REP-1.

Authors:  Jesse D Sengillo; Winston Lee; Mathieu F Bakhoum; Galaxy Y Cho; John P-W Chiang; Stephen H Tsang
Journal:  Retin Cases Brief Rep       Date:  2018 Fall

2.  Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures.

Authors:  Rait Parmann; Vivienne C Greenstein; Stephen H Tsang; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

3.  Pathogenic mechanisms and the prospect of gene therapy for choroideremia.

Authors:  Ioannis S Dimopoulos; Stephanie Chan; Robert E MacLaren; Ian M MacDonald
Journal:  Expert Opin Orphan Drugs       Date:  2015-07-01       Impact factor: 0.694

Review 4.  Gene-Based Therapeutics for Inherited Retinal Diseases.

Authors:  Beau J Fenner; Tien-En Tan; Amutha Veluchamy Barathi; Sai Bo Bo Tun; Sia Wey Yeo; Andrew S H Tsai; Shu Yen Lee; Chui Ming Gemmy Cheung; Choi Mun Chan; Jodhbir S Mehta; Kelvin Y C Teo
Journal:  Front Genet       Date:  2022-01-07       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.